JPH0455200B2 - - Google Patents

Info

Publication number
JPH0455200B2
JPH0455200B2 JP59217312A JP21731284A JPH0455200B2 JP H0455200 B2 JPH0455200 B2 JP H0455200B2 JP 59217312 A JP59217312 A JP 59217312A JP 21731284 A JP21731284 A JP 21731284A JP H0455200 B2 JPH0455200 B2 JP H0455200B2
Authority
JP
Japan
Prior art keywords
human
plasmin inhibitor
plasmin
inhibitor
monoclonal antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59217312A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6197230A (ja
Inventor
Yoshihiko Washimi
Yukya Koike
Yataro Ichikawa
Nobuhiko Yoshida
Nobuo Aoki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP59217312A priority Critical patent/JPS6197230A/ja
Priority to DK170485A priority patent/DK166627B1/da
Priority to NO851518A priority patent/NO171169C/no
Priority to EP85104629A priority patent/EP0159025B1/en
Priority to DE3587714T priority patent/DE3587714T2/de
Publication of JPS6197230A publication Critical patent/JPS6197230A/ja
Priority to US07/716,694 priority patent/US5534255A/en
Publication of JPH0455200B2 publication Critical patent/JPH0455200B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP59217312A 1984-04-17 1984-10-18 ヒトα↓２―プラスミンインヒビターに対する選択的吸着体 Granted JPS6197230A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP59217312A JPS6197230A (ja) 1984-10-18 1984-10-18 ヒトα↓２―プラスミンインヒビターに対する選択的吸着体
DK170485A DK166627B1 (da) 1984-04-17 1985-04-16 Monoklont antistof, der er specifikt over for human-alfa-2-plasmininhibitor, fremgangsmaade til fremstilling af et hybridom, der producerer antistoffet, anvendelse af antistoffet til immunologisk analyse for human-alfa-2-plasmininhibitor og anvendelse af antistoffet til fraskillelse og udvinding af human-alfa-2-plasmininhibitor
NO851518A NO171169C (no) 1984-04-17 1985-04-16 Monoklonale antistoffer eller fragmenter derav, spesifikke for alfa2-plasmininhibitor
EP85104629A EP0159025B1 (en) 1984-04-17 1985-04-17 Monoclonal antibody specific to human alpha2-plasmin
DE3587714T DE3587714T2 (de) 1984-04-17 1985-04-17 Menschliches alpha 2-Plasmin spezifischer monoklonaler Antikörper.
US07/716,694 US5534255A (en) 1984-04-17 1991-06-17 Monoclonal antibody specific to human α2 -plasmin inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59217312A JPS6197230A (ja) 1984-10-18 1984-10-18 ヒトα↓２―プラスミンインヒビターに対する選択的吸着体

Publications (2)

Publication Number Publication Date
JPS6197230A JPS6197230A (ja) 1986-05-15
JPH0455200B2 true JPH0455200B2 (enrdf_load_stackoverflow) 1992-09-02

Family

ID=16702182

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59217312A Granted JPS6197230A (ja) 1984-04-17 1984-10-18 ヒトα↓２―プラスミンインヒビターに対する選択的吸着体

Country Status (1)

Country Link
JP (1) JPS6197230A (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2520424B2 (ja) * 1987-07-03 1996-07-31 帝人株式会社 血液線溶活性の測定方法
JPH01233298A (ja) * 1988-03-11 1989-09-19 Boehringer Mannheim Gmbh 抗体、その製造法、ｈｍｌｃを測定するための試薬、ならびにモノクローナル抗体

Also Published As

Publication number Publication date
JPS6197230A (ja) 1986-05-15

Similar Documents

Publication Publication Date Title
JPH0636741B2 (ja) ヒト・プロテインｃの分離方法
EP0162078B1 (en) Method for isolating a protein from a mixture containing said protein and a conformation specific antibody useful therein
US5534255A (en) Monoclonal antibody specific to human α2 -plasmin inhibitor
KR960002740B1 (ko) 안티-트롬빈-결합물질 모노클로날 항체, 이를 생산하는 하이브리도마 및 모노클로날 항체를 이용한 트롬빈-결합물질의 정제법 및 측정법
JPH0455200B2 (enrdf_load_stackoverflow)
US5187067A (en) Immunological determination of free human protein S and C4bp-protein S complex
AU590216B2 (en) Anti-urokinase monoclonal antibody; its production and use
EP0205046B1 (en) Monoclonal antibody to human protein c
US5411864A (en) Method of purifying recombinant proteins from corresponding host cell proteins
JPH0535827B2 (enrdf_load_stackoverflow)
Nishikado et al. Murine monoclonal antibodies to human factor XI
JP3226942B2 (ja) スロンビンとスロンビン阻害物質とにより形成された複合体に対して向けられたモノクローナル抗体
JP2868530B2 (ja) プラスミノーゲンアクティベーターインヒビターに対するモノクローナル抗体
JPH0441782B2 (enrdf_load_stackoverflow)
JPH0344760B2 (enrdf_load_stackoverflow)
JP2750732B2 (ja) ヒトプラスミノーゲンアクティベーターインヒビター・１−ヒト組織プラスミノーゲンアクティベーター複合体の免疫学的測定方法
JP2518602B2 (ja) ヒトプロテインｓに対するモノクロ―ナル抗体を用いた免疫学的測定試薬及びキット
JPH0535826B2 (enrdf_load_stackoverflow)
JPH0260267B2 (enrdf_load_stackoverflow)
JPH0789116B2 (ja) モノクローナル抗体を用いた免疫学的測定方法およびそのためのキット
JPH031959B2 (enrdf_load_stackoverflow)
JPH0441783B2 (enrdf_load_stackoverflow)
JPH03187396A (ja) 抗体，抗体産生ハイブリドーマおよび抗体の用途
JPH052310B2 (enrdf_load_stackoverflow)
JPH03200066A (ja) 活性化ヒトプロテインｃの測定方法

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees